INSIST! Non-Small Cell Lung Cancer

September 2023

Biomarker testing in lung cancer is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! Lung Cancer is to educate and empower patients and care partners to speak up and insist on better care.

Program topics include:

Personalize Your Experience!

Create an account to save items and receive information curated just for you.

Understanding Testing in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer Treatment Decisions

This program is supported by Amgen, Daiichi-Sankyo, Foundation Medicine, Illumina, Novartis, and through generous donations from people like you.

Share On:

Facebook
Twitter
LinkedIn